Skip to content
Biograil™
  • The Technology
  • The Company
    • Team members
    • Board
    • Investors
    • Scientific Advisory Board
  • Contact us
  • News
  • Careers
Biograil™
Close menu
  • The Technology
  • The Company
    • Team members
    • Board
    • Investors
    • Scientific Advisory Board
  • Contact us
  • News
  • Careers
Biograil™
Toggle menu

Author: Karsten Lindhardt

December 18, 2025December 18, 2025News

Press Release: Robert (Bob) Radie and Ulrik Schulze Join the Biograil Board of Directors

COPENHAGEN, DENMARK, Dec 17th, 2025 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]

July 1, 2025July 1, 2025News

Press Release: Biograil raises EUR 8.5 million to support clinical testing of oral therapeutic delivery device

COPENHAGEN, DENMARK, July 1st, 2025 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]

July 17, 2024November 20, 2024News

Press Release: Biograil and CSL Sign Collaboration Agreement for development of certain CSL compounds using Biograil’s proprietary BIONDD™ technology.

COPENHAGEN, DENMARK, July 17th, 2024 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]

Legal

Privatlivspolitik Cookiepolitik
© 2025 Biograil ApS. All Rights Reserved

Langebjerg 1, 4000 Roskilde, Denmark

Terms of Use And Privacy Policy